Stocks screened from BSE and NSE with consistent score improvement over the past week, minimum 16% analyst upside, and market cap above ₹30,000 crore. Data from Refinitiv SR Plus report dated April 18, 2026.
Abbott India
Pharma
Score driver: Price momentum improvement
Grade: AP&G Hygiene & Health Care
FMCG
Score driver: Relative valuation improvement
Grade: AHavells India
Electricals
Score driver: Earnings component improvement
Grade: ADalmia Bharat
Cement
Score driver: Earnings component improvement
Grade: B+L&T Technology Services
IT / Engineering R&D
Score driver: Price momentum, earnings & valuation
Grade: AHow stocks were filtered
- 1Consistent score improvement over the past one week compared to prior week's average score
- 2Analyst recommendation of Strong Buy, Buy, or Hold (I/B/E/S via Refinitiv) — mapped to grades A, A, and B+ respectively
- 3Minimum upside potential of 16% based on 12-month mean analyst price targets
- 4Market capitalisation of at least ₹30,000 crore
How scores are calculated
Earnings
Earnings surprises, estimate revisions, and recommendation changes over recent periods
Price momentum
Relative strength vs industry average + seasonality in historical returns
Fundamentals
Profitability, debt levels, earnings quality, and dividend ratings
Risk
Return magnitude, volatility, beta vs Sensex, and peer correlation
Relative valuation
Price-to-sales (50%), trailing PE (25%), and forward PE (25%) vs history and Sensex
Scores run from 1–10. A score of 8–10 is positive, 4–7 is neutral, 1–3 is negative. The five component scores are averaged into a single overall score.
Source: Refinitiv SR Plus, April 18, 2026. This content is for informational purposes only and does not constitute investment advice. Consult a certified professional before making any investment decision.
